Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.
Aegle Therapeutics has raised $456K in total funding. The most recent round was Debt Financing. The last funding was announced in March 2026.
Aegle Therapeutics's investors include DeepWork Capital, Ocean Azul Partners, DEFTA Partners, New World Angels, Tellus BioVentures.
Aegle Therapeutics is headquartered in Miami, United States.
Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.
Aegle Therapeutics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aegle Therapeutics — Funding & Investors." VCBacked, March 3, 2026, https://www.vcbacked.co/company/aegle-therapeutics. Accessed November 13, 2026.
VCBacked. (2026). Aegle Therapeutics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/aegle-therapeutics
{{cite web |title=Aegle Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aegle-therapeutics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Aegle Therapeutics? Request a listing update